Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 31.96M | $150.0M | 18.03% | +7.27M | 2026-03-31 |
| Kynam Capital Management, LP | 15.01M | $70.0M | 8.47% | +6.05M | 2026-03-31 |
| BANK OF AMERICA CORP /DE/ | 10.20M | $47.0M | 5.76% | +9.33M | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 10.10M | $47.0M | 5.70% | +418.6K | 2026-03-31 |
| VR ADVISER, LLC | 9.98M | $46.0M | 5.63% | -5.58M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.73M | $41.0M | 4.93% | -- | 2026-03-31 |
| Point72 Asset Management, L.P. | 7.88M | $37.0M | 4.44% | +2.69M | 2026-03-31 |
| CITADEL ADVISORS LLC | 5.90M | $27.0M | 3.33% | +5.43M | 2026-03-31 |
| STATE STREET CORP | 5.66M | $26.0M | 3.19% | +522.5K | 2026-03-31 |
| BlackRock, Inc. | 5.23M | $24.0M | 2.95% | +1.56M | 2026-03-31 |
